Latest Intellectual Property News

Sparc Technologies has unveiled SparcESTM, a graphene additive range designed for electrostatic and conductive coatings, aiming to disrupt a $1.65 billion market driven by data centres, semiconductors, and EV battery manufacturing.

ClearVue Technologies is inviting eligible shareholders to participate in a $1 million Share Purchase Plan at a discount, following a $5 million institutional placement. The capital raised will support ERP rollout, R&D, and working capital.

Mesoblast has drawn US$50 million from a new five-year facility that reduces its interest burden and retires expensive short-term debt, strengthening its financial position ahead of commercial expansion.

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.

RTO Limited reported a net loss of NZD 173,831 for the year ended 31 March 2026, remaining inactive while actively seeking a reverse takeover target. The company faces going concern uncertainty but secured shareholder support with a $200k loan agreement post-year-end.

Pathkey.AI has finalised its takeover of Chipforge, an AI-driven semiconductor design company, issuing shares and performance rights as consideration. The move broadens Pathkey's AI platform capabilities from clinical trials into semiconductor engineering, aiming to shorten chip development cycles significantly.

Calix’s Leilac unit has teamed up with Ambuja Cements to trial a commercial-scale carbon capture retrofit at the Sanghi plant, aiming to slash emissions and fuel costs without upfront capital.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Nanoveu’s ECS-DoT AI chip has demonstrated up to 27.8% improvement in drone cruise energy efficiency in live flight tests, achieving gains without any hardware changes and consuming negligible power.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.

Critical Resources has scaled its solid-state battery program from coin cells to full-format pouch cells, marking a key manufacturing milestone with electrochemical testing now underway. The next phase aims to integrate its proprietary sulphur-free solid-state electrolyte into these cells.

Victory Metals has achieved a major processing milestone at its North Stanmore Project, producing a 7.1% Total Rare Earth Oxide concentrate with 40% heavy rare earth oxides through continuous flotation at pilot scale.